Prospective Agreement Study of Magnetic Resonance Imaging Measurements and Intraoperative Dimensions During Gluteal Permanent Synthetic Filler Removal
1 other identifier
observational
220
0 countries
N/A
Brief Summary
This prospective agreement study will compare preoperative MRI measurements with direct surgical measurements in adults undergoing removal of gluteal tissue affected by permanent synthetic fillers. MRI will estimate affected-tissue dimensions and residual skin-flap thickness at predefined landmarks. During surgery, the same flap landmarks and the fresh excised specimen will be measured. The primary outcome is agreement between MRI and intraoperative flap thickness; postoperative ischemia, wound dehiscence, and necrosis will be followed through 30 days.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 1, 2026
CompletedFirst Posted
Study publicly available on registry
September 9, 2026
CompletedStudy Start
First participant enrolled
October 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
ExpectedSeptember 9, 2026
September 1, 2026
Same day
September 1, 2026
September 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Agreement Between MRI and Intraoperative Residual Flap Thickness
Residual skin-subcutaneous flap thickness in millimeters will be measured at predefined mapped landmarks on MRI and directly during surgery. Agreement will be summarized using intraclass correlation, mean bias, 95% limits of agreement, and absolute error.
Preoperative MRI within 90 days before surgery and the index surgical procedure. 90 days
Secondary Outcomes (3)
Agreement Between MRI and Fresh-Specimen Affected-Tissue Dimensions
Preoperative MRI within 90 days before surgery and immediately after specimen removal during the index operation. 90 days
Absolute Percentage Error in Predicted Affected-Tissue Volume
Preoperative MRI and the index surgical procedure. 1 day
Incidence of Ischemic Wound Complications
From surgery through postoperative day 30. 30 days
Study Arms (1)
MRI-to-Surgery Agreement Cohort (Cohort)
Participants undergo preoperative MRI morphometry followed by standardized intraoperative flap and specimen measurements during clinically indicated filler removal.
Interventions
Before closure, residual flap thickness will be measured with a calibrated sterile device at the same mapped landmarks without compressing the tissue. The fresh excised block will be oriented and measured in three axes before fixation. Specimen weight will also be recorded. Linked arm/group(s): MRI-to-Surgery Agreement Cohort.
Three orthogonal dimensions of the affected block and residual flap thickness at fixed surface landmarks will be measured on MRI by two trained readers. Affected-tissue volume will be estimated using segmentation when available and a prespecified geometric approximation otherwise. Linked arm/group(s): MRI-to-Surgery Agreement Cohort.
Eligibility Criteria
Adults scheduled for surgical excision of gluteal tissue affected by permanent synthetic fillers after preoperative MRI.
You may qualify if:
- Age 18 years or older.
- Gluteal permanent synthetic filler disease scheduled for elective surgical excision.
- Preoperative MRI performed within 90 days before surgery using the study measurement protocol.
- Planned skin/subcutaneous flap elevation that permits direct thickness measurement at predefined landmarks.
- Written informed consent.
You may not qualify if:
- Emergency surgery or active uncontrolled infection that prevents standardized preoperative imaging or measurement.
- Prior surgery causing loss of the predefined landmarks or making paired measurement impossible.
- Nondiagnostic MRI or incomplete coverage of the planned operative field.
- Specimen fragmentation that prevents standardized fresh-specimen dimension measurement for the secondary endpoint.
- Inability to complete 30-day wound follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Research Inclead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Edison Osorio, MD, plastic surgery
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 1, 2026
First Posted
September 9, 2026
Study Start
October 1, 2026
Primary Completion
October 1, 2026
Study Completion (Estimated)
December 1, 2027
Last Updated
September 9, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
patient consent signed before do not take in account share the information on that way